DNA sequencing company Illumina and Nashville Biosciences, a wholly owned subsidiary of Nashville, Tenn.-based Vanderbilt University Medical Center, are working with biopharmaceutical company Amgen to whole-genome sequence approximately 35,000 DNA samples from a mostly African American cohort.
Read the full post on Becker's Hospital Review - Healthcare News
